1. Home
  2. THRM vs VOR Comparison

THRM vs VOR Comparison

Compare THRM & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gentherm Inc

THRM

Gentherm Inc

HOLD

Current Price

$36.10

Market Cap

968.2M

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$14.39

Market Cap

813.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRM
VOR
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.2M
813.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
THRM
VOR
Price
$36.10
$14.39
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$37.20
$45.33
AVG Volume (30 Days)
265.4K
724.9K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$554,979,000.00
N/A
Revenue This Year
$4.96
N/A
Revenue Next Year
$7.12
N/A
P/E Ratio
$250.43
N/A
Revenue Growth
50.16
N/A
52 Week Low
$27.00
$0.18
52 Week High
$39.48
$49.95

Technical Indicators

Market Signals
Indicator
THRM
VOR
Relative Strength Index (RSI) 59.82 49.47
Support Level $35.66 $13.73
Resistance Level $35.90 $14.73
Average True Range (ATR) 1.40 0.96
MACD -0.04 -0.08
Stochastic Oscillator 55.69 56.48

Price Performance

Historical Comparison
THRM
VOR

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: